Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Publications section now notes that PubMed publications are automatically filled and may not relate to the study, and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe funding status notice was removed from the page, and the study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedNo meaningful changes detected between the two screenshots of the Study Details page for NCT01585194.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

- Check69 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0 with substantial addition of immunology-related terms and related categories.SummaryDifference1%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element has been removed. Core content remains unchanged.SummaryDifference0.2%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.